Stevens-Johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy

Pediatric Nephrology

Volumn 18, Issue 9, 2003, Pages 959-961

  Jo, Dae Sun ^a   Yang, Jun Won ^a   Hwang, Pyoung Han ^a   Lee, Dae Yeol ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Intravenous methylprednisolone; Nephrotic syndrome; Prednisolone; Stevens Johnson syndrome

Indexed keywords

ALUMINUM ACETATE; CALAMINE; CEFAZOLIN; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; AGE; ANUS; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EYE; FEVER; GENDER; HUMAN; HUMAN TISSUE; IMMUNE STATUS; LIP; MALE; MOUTH CAVITY; MUCOSA; NEPHROTIC SYNDROME; PAPULAR SKIN DISEASE; PRIORITY JOURNAL; PRURITUS; RECTUM; SKIN DEFECT; SKIN DISEASE; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; TIME;

ADMINISTRATION, ORAL; ADOLESCENT; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PREDNISOLONE; STEVENS-JOHNSON SYNDROME;

EID: 0141857906     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1215-0     Document Type: Article

References (11)

1. Habif TP (1996) Clinical dermatology, 3rd edn. Mosby Year-book, St. Louis, pp 566-596
2. Rasmussen JE (2002) Erythema multiforme: a practical approach to recent advances. Pediatr Dermatol 19:82-84
3. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-1607
4. Patterson R, Dykewicz MS, Gonzalzles A, Grammer LC, Green D, Greenberger PA, McGrath KG, Walker CL (1990) Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest 98:331-336
5. Martinez AE, Atherton DJ (2000) High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme. Pediatr Dermatol 17:87-90
6. Samimi SS, Siegfried E (2002) Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high dose corticosteroid therapy. Pediatr Dermatol 19:52-55
7. Sullivan JR, Shear NH (2001) The drug hypersensitivity syndrome. What is the pathogenesis? Arch Dermatol 137:357-364
8. Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272-1285
9. Assier-Bonnet H, Aractingi S, Cadranel J, Wechsler J, Mayaud C, Saiag P (1996) Stevens-Johnson syndrome induced by cyclophosphamide: report of two cases. Br J Dermatol 135: 852-866
10. Duarte AM (2000) Proceedings of the 1999 meeting of the Society for Pediatric Dermatology. Pediatr Dermatol 1:75-83
11. Kakourou T, Klontza D, Soteropoulou F, Kattamis C (1997) Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J Pediatr 156:90-93